← Back to Clinical Trials
Recruiting NCT07447089

NCT07447089 EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447089
Status Recruiting
Phase —
Sponsor Università Cattolica di Milano
Condition Thyroid Neoplasms
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2025-12-05
Primary Completion 2026-10-01

Trial Parameters

Condition Thyroid Neoplasms
Sponsor Università Cattolica di Milano
Study Type INTERVENTIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2025-12-05
Completion 2026-10-01
Interventions
EMDR-IGTP-OTS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.

Eligibility Criteria

Inclusion Criteria: * cancer diagnosis * PTSD (IES-R \> 32) Exclusion Criteria: * receiving specialized trauma therapy * receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE THYROID NEOPLASMS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology